Muscle & Brawn 2.0 is live! New Tools, Voice Reader, Compound Index, Features and more on the way. Want to explore what’s new → Click Here
Independent & reader-supported — every article medically reviewed
Peptides

SS-31 Peptide Guide – Benefits, Dosage, Side Effects

SS-31 is a Peptide that can enhance your mitochondrial function and optimize your energy levels so that you can always feel energized!

Updated 10 min read
SS-31 peptide guide: glowing mitochondrion model in a research lab with cell biology displays
Contents11 sections

The SS-31 peptide (Elamipretide) is a synthetic tetrapeptide that targets the inner mitochondrial membrane to restore mitochondrial function and energy production. Unlike most peptides that work through hormonal pathways, SS-31 operates at the cellular energy level by binding to cardiolipin, a phospholipid essential for mitochondrial structure and electron transport.

The result is improved ATP production, reduced oxidative stress, and better cellular energy output. Research on SS-31 has shown benefits for skeletal muscle function, cardiovascular health, kidney protection, and age-related cognitive decline. The Elamipretide peptide is currently in clinical trials for conditions including Barth syndrome and primary mitochondrial myopathy.

Even though this might sound a little complex, I got you like always, as I have tried my best to break down the working of SS-31 for you! Stay with me till the end to find out about this peptide and to decide if it fits your requirements. 

SS-31 (Elamipretide) is an experimental peptide currently in clinical trials. It is not FDA-approved and is available only as a research chemical. The information in this article is for educational purposes only and does not constitute medical advice. All efficacy and safety data referenced comes from preclinical research and early-phase clinical trials. Consult a qualified healthcare professional before using any research peptide.

Key Takeaways

  • SS-31 (Elamipretide) is a mitochondria-targeted peptide that binds to cardiolipin in the inner mitochondrial membrane to restore electron transport and ATP production.
  • Research demonstrates benefits for skeletal muscle function, exercise tolerance, cardiovascular health, kidney protection, and age-related cognitive decline.
  • The typical research dosage is 0.5-2 mg/day via subcutaneous injection, with 40 mg shown to be well-tolerated in human subjects.
  • SS-31 is currently in clinical trials for Barth syndrome and primary mitochondrial myopathy. It is not FDA-approved for general use.
  • Common SS-31 side effects are limited to injection site reactions (redness, itching) and mild headache.

What Is the SS-31 Peptide?

The SS-31 peptide, also known as Elamipretide or Szeto-Schiller peptide 31, is an aromatic synthetic tetrapeptide with the sequence D-Arg-dimethylTyr-Lys-Phe-NH2 and a molecular weight of 639.8 g/mol. It belongs to a class of small, cell-permeable, water-soluble peptides that carry a net charge of 3+ at physiological pH.

What makes SS-31 unique among peptides is its target: rather than binding to cell surface receptors or modulating hormones, it crosses the cell membrane and accumulates specifically in the inner mitochondrial membrane. This targeting happens independently of mitochondrial membrane potential, meaning SS-31 can reach even damaged or dysfunctional mitochondria.

Quick Facts

PropertyDetail
Also known asElamipretide, MTP-131, Bendavia
StructureD-Arg-dimethylTyr-Lys-Phe-NH2
Molecular weight639.8 g/mol
TargetInner mitochondrial membrane (cardiolipin)
AbsorptionRapid cellular uptake within 15-30 minutes
AdministrationSubcutaneous injection, intranasal spray
Clinical statusPhase 2/3 trials for Barth syndrome and mitochondrial myopathy

How Elamipretide Works: Mechanism of Action

Fig 1. SS-31 reverses mitochondrial functioning in mitochondrial cardiomyopathy 
Fig 2. Effects of SS-31 on mitochondrial dysfunction, synaptic transmission, and memory impairment 

The SS-31 peptide operates through a specific mitochondrial pathway that distinguishes it from other performance or anti-aging peptides.

Step 1: Rapid Cellular Uptake

SS-31 enters cells independently of energy-dependent transporters or receptor-mediated processes. It is absorbed within 15-30 minutes and is relatively resistant to peptidase degradation, which allows for a longer duration of action.

Step 2: Cardiolipin Binding

Once inside the cell, SS-31 accumulates in the inner mitochondrial membrane and binds selectively to cardiolipin, an anionic phospholipid essential for mitochondrial structure and function. When cardiolipin becomes damaged or oxidized (common in aging and disease), it converts cytochrome c from an electron carrier into a peroxidase, disrupting the electron transport chain.

SS-31 prevents this conversion by stabilizing the cardiolipin-cytochrome c interaction, keeping cytochrome c in its electron-carrying role.

Step 3: Electron Transport Chain Restoration

By protecting the cardiolipin-cytochrome c relationship, SS-31 restores normal electron transport chain function. This directly increases ATP synthesis, the primary energy currency of the cell.

Step 4: Oxidative Stress Reduction

SS-31 contains dimethyl tyrosine residues that scavenge reactive oxygen species (ROS) and form unreactive tyrosine radicals. This antioxidant activity reduces oxidative phosphorylation of linoleic acid and low-density lipoprotein, protecting mitochondrial structures from further damage.

Step 5: Cristae Remodeling

The inner mitochondrial membrane contains folds called cristae, whose degradation is associated with aging. SS-31 enhances cardiolipin activity to remodel these cristae structures, contributing to its anti-aging effects at the cellular level.


SS-31 Benefits

Improved Skeletal Muscle Function

Mitochondrial dysfunction reduces ATP availability in muscle cells, leading to fatigue and poor exercise tolerance. SS-31 restores mitochondrial energy output, which research has shown improves skeletal muscle function and exercise capacity. This is the primary SS-31 benefit that attracts athletes and bodybuilders, many of whom already use creatine supplements for complementary ATP support through a different pathway.

Cardiovascular Protection

Cardiac muscle cells are among the most mitochondria-dense cells in the body. SS-31 benefits cardiovascular health by maintaining the proton leak mechanism in cardiac mitochondria, reducing ROS production, and protecting against diastolic dysfunction. Research has demonstrated its potential in ischemia-reperfusion injury and heart failure models.

Neuroprotective Effects

The antioxidant properties of SS-31 extend to neural tissue. Studies in mice have shown improved cerebral microvascular dilation, better memory retention, enhanced motor skills, and improved gait coordination after SS-31 treatment. The peptide specifically counters hippocampal oxidative stress, making it a subject of research for Alzheimer’s disease intervention.

Kidney Protection

SS-31 has shown efficacy in countering ischemia-reperfusion injury in chronic kidney disease models. By regenerating ATP levels in renal cells, it protects against the energy deficit that drives kidney damage in CKD.

Anti-Aging at the Cellular Level

Age-related mitochondrial decline is a primary driver of cellular aging. SS-31 addresses this by:

  • Remodeling degraded mitochondrial cristae
  • Preventing proton leak through cooperation with the ANT1 protein
  • Reducing oxidative stress that accumulates with age
  • Restoring ATP production to more youthful levels

Islet Cell Preservation

Research has demonstrated that SS-31 reduces apoptosis and inflammatory responses in mouse islet cells, increasing islet cell yield by preserving mitochondrial function. This finding has implications for improving insulin resistance and supporting transplanted islet cells in diabetes treatment.


SS-31 Dosage

Human Trial Data

ParameterDetail
Well-tolerated doseUp to 40 mg in human subjects
Common research dose0.5-2 mg/day
AdministrationSubcutaneous or intramuscular injection
Alternative deliveryIntranasal spray
Cycle approachVaries by condition; some protocols run until resolution

Important Considerations

  • The appropriate SS-31 dosage varies significantly based on the condition being targeted. Cardiovascular applications may require different dosing than skeletal muscle or neurological use cases.
  • The 40 mg figure comes from tolerability studies, not from optimized efficacy data. Research protocols often use lower doses.
  • Consult a healthcare practitioner for personalized SS-31 peptide dosing. Self-dosing based on animal study extrapolations carries significant uncertainty.

Administration Methods

MethodNotes
Subcutaneous injectionMost common in research and clinical trials. Standard peptide injection sites apply.
Intramuscular injectionAlternative to subcutaneous; may provide faster absorption
Intranasal sprayNon-invasive option with increasing availability; clean nostrils before administration
Pre-mixed pensNewer delivery method; portable and convenient

SS-31 Side Effects

SS-31 has a favorable side effect profile compared to many research peptides. The most commonly reported effects are mild and temporary.

Common Side Effects

Side EffectFrequencySeverity
Injection site reactionsCommonMild (redness, itching)
HeadacheOccasionalMild
DizzinessRareMild

Safety Considerations

  • No serious SS-31 side effects have been reported in human tolerability studies at doses up to 40 mg
  • Long-term safety data is limited as the peptide is still in clinical trials
  • The peptide does not appear to accumulate in the mitochondrial matrix even at high concentrations, which may contribute to its favorable safety profile
  • As with any injectable peptide, proper reconstitution and sterile technique are essential to avoid infection

SS-31 vs. Other Mitochondrial Peptides

SS-31 vs. MOTS-C

FeatureSS-31MOTS-C
OriginSynthetic tetrapeptideMitochondria-derived peptide (MDP)
TargetInner mitochondrial membrane (cardiolipin)AMPK pathway, nuclear gene regulation
Primary functionRestores electron transport chain, ATP productionRegulates glucose metabolism, insulin sensitivity
Best forMitochondrial dysfunction, energy production, anti-agingMetabolic health, fat loss, exercise performance
Anti-agingYes (cristae remodeling, oxidative stress reduction)Yes (metabolic regulation, cellular stress response)
AdministrationSubcutaneous injection, intranasalSubcutaneous injection
AvailabilityLimited; expensiveMore widely available from research vendors

SS-31 acts directly on mitochondrial structure, while MOTS-C influences mitochondrial function through metabolic signaling pathways. For bodybuilders and athletes primarily interested in energy and exercise tolerance, MOTS-C is generally more accessible and has broader user experience data. SS-31 may be better suited for addressing specific mitochondrial dysfunction or age-related energy decline.

SS-31 vs. Humanin

Both SS-31 and Humanin improve mitochondrial function and have anti-aging potential, but they differ fundamentally:

  • SS-31 is synthetic and accumulates in the inner mitochondrial membrane to restore electron transport directly
  • Humanin is a naturally occurring mitochondria-derived peptide with broader systemic effects including cytoprotection, anti-inflammatory signaling, and metabolic regulation

Humanin has more diverse biological functions beyond mitochondrial support, while SS-31 is more targeted and specific in its mechanism.


Where to Buy Elamipretide (SS-31)

SS-31 peptide availability is limited compared to more common research peptides. The peptide is expensive and not widely stocked by major peptide vendors. As of 2026:

  • Research chemical vendors: A small number of vendors carry SS-31, but availability fluctuates. Check vendors on our best peptide vendors list for current stock.
  • Clinical access: The Elamipretide peptide (the pharmaceutical version) is available through clinical trials. Check ClinicalTrials.gov for active trials.
  • Alternatives: Many users opt for MOTS-C as a more accessible mitochondrial peptide with similar energy-boosting benefits.

The Bottom Line

The SS-31 peptide represents one of the most targeted approaches to mitochondrial repair available in the peptide space.

  • Its ability to bind directly to cardiolipin and restore electron transport chain function sets it apart from peptides that work through hormonal or metabolic pathways.
  • The research supporting its SS-31 benefits, from skeletal muscle function to cardiovascular protection to neuroprotection, is compelling and continues to grow through ongoing clinical trials.

Frequently Asked Questions

SS-31 targets the inner mitochondrial membrane by binding to cardiolipin, a phospholipid essential for electron transport. This restores ATP production, reduces oxidative stress, and improves cellular energy output. Research has shown SS-31 benefits for skeletal muscle function, cardiovascular protection, neuroprotection, and kidney health.
No. SS-31, also known as the Elamipretide peptide, is currently in clinical trials for Barth syndrome and primary mitochondrial myopathy. It has not received FDA approval for any indication. The peptide is available only as a research chemical or through clinical trial enrollment.
Human tolerability studies have shown that an SS-31 dosage of up to 40 mg is well-tolerated. Common research protocols use 0.5-2 mg/day via subcutaneous injection. Dosage varies significantly based on the target condition. Consult a healthcare practitioner for guidance.
The most common SS-31 side effects are mild injection site reactions (redness, itching) and occasional headache. No serious adverse events have been reported in clinical studies. The peptide has a favorable safety profile compared to many research compounds, though long-term data is still limited.
SS-31 directly targets the inner mitochondrial membrane to restore electron transport and ATP production. MOTS-C works through the AMPK pathway to regulate glucose metabolism and insulin sensitivity. Both support mitochondrial function, but through different mechanisms. MOTS-C is more widely available and has more user experience data, while SS-31 is more targeted for specific mitochondrial dysfunction.
The SS-31 peptide is available as a research chemical in most countries, similar to other research peptides. It is not approved for human consumption by any regulatory agency. For a full breakdown of peptide regulations, see our peptide legality guide.

Disclaimer

Please read carefully

The information on this site is for educational and informational purposes only, and is not medical advice. Always consult a qualified healthcare professional before using any supplement or medication, or making changes to your health, fitness, or nutrition routine.

Not medical advice

Content here is not a substitute for professional medical advice.

Consult your doctor

Talk to your doctor before starting any supplement or new routine.

Use at your own risk

We are not responsible for adverse effects from acting on this.

Do your research

Make informed decisions about your own health.

No guarantees

Individual results vary. No claims about outcomes.

Important — Never disregard professional medical advice or delay seeking it because of something you read here. If you think you may have a medical emergency, call your doctor or your local emergency number right away.

Written & researched by

Farah Jassawalla

The Morning Dose · Free weekly

The research that matters, in five minutes a week.

Join 300,000+ monthly readers getting the sharpest peptide, TRT, and SARMs research and news broken down without the hype. One email. No filler.

No spam. Unsubscribe anytime. 5-minute read, every week.
Latest issue #1

The Morning Dose #1: MK-677 vs HGH, Syringe Math Made Easy, and What HCG Really Protects

MK-677 vs HGH: what seven clinical trials show
Peptide Dosage Calculator: your exact syringe mark
HCG for Bodybuilding: fertility, recovery and side effects
Read time · 1 min Read this issue →

Our Trusted Brands

Our growing community of brands that value quality and innovation.